Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $194000.0.

  • Orchestra BioMed Holdings' Amortizatization of Intangibles fell 4550.56% to $194000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $722000.0, marking a year-over-year decrease of 6215.93%. This contributed to the annual value of $1.5 million for FY2024, which is 6069.65% down from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Amortizatization of Intangibles stood at $194000.0, which was down 4550.56% from $150000.0 recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Amortizatization of Intangibles peaked at $1.1 million during Q3 2023, and registered a low of $132000.0 during Q1 2022.
  • Moreover, its 4-year median value for Amortizatization of Intangibles was $231000.0 (2024), whereas its average is $427400.0.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Amortizatization of Intangibles skyrocketed by 70000.0% in 2023, and later tumbled by 7504.24% in 2025.
  • Over the past 4 years, Orchestra BioMed Holdings' Amortizatization of Intangibles (Quarter) stood at $181000.0 in 2022, then soared by 252.49% to $638000.0 in 2023, then plummeted by 63.79% to $231000.0 in 2024, then fell by 16.02% to $194000.0 in 2025.
  • Its last three reported values are $194000.0 in Q3 2025, $150000.0 for Q2 2025, and $147000.0 during Q1 2025.